在乳腺癌中,依赖于阿迪普辛的脂肪细胞成熟会诱导癌细胞入侵
Jumpei Yoshida1,2, Takanori Hayashi1, Eiji Munetsuna1
1Department of Biochemistry, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 4701192, Japan.
Scientific reports
|August 9, 2024
概括
由素 (CFD) 驱动的脂肪细胞成熟,增强乳腺癌细胞入侵和转移. 抑制素可以减少瘤的生长和扩散,突出其在脂肪细胞与癌细胞相互作用中的作用.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 内分泌学 在内分泌学.
背景情况:
- 脂肪细胞与癌细胞的相互作用在瘤发育中至关重要.
- 素 (CFD) 和肝细胞生长因子 (HGF) 之前被确定为调解这些相互作用的素.
研究的目的:
- 调查素依赖性脂肪细胞成熟在促进乳腺癌入侵中的作用.
- 阐明脂肪细胞影响乳腺癌进展的机制.
主要方法:
- 与成熟的脂肪细胞及其前体共同培养乳腺癌细胞.
- 使用素淘汰 (Cfd KO) 模型和竞争性抑制剂.
- 将癌细胞移植到Cfd KO小鼠身上进行体内研究.
- 进行瘤组织的组织学分析.
主要成果:
- 成熟的脂肪细胞,但不是前体,显著诱导癌细胞迁移和侵入以依赖素的方式.
- 脂肪细胞诱导的侵袭促进体 (银质素7,矩阵金属蛋白酶) 的上调受素抑制而降低.
- 在Cfd KO小鼠中,瘤生长和转移被抑制.
- 在Cfd KO小鼠中观察到减少囊形成和癌症脂肪细胞接口的入侵.
结论:
- 素依赖的脂肪细胞成熟促进乳腺癌的侵袭和进展.
- 阿迪普辛在调解脂细胞与癌细胞相互作用中发挥着重要作用,这些相互作用推动了瘤的攻击性.
- 向素可能为乳腺癌提供治疗策略.
相关概念视频
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K


